Dordaviprone + Mao Inhibitors Interaction
Majorinteraction on record
Description
Strong CYP3A4 inhibitors increase dordaviprone exposure, which may increase the risk of MODEYSO-related adverse reactions. Avoid concomitant use or reduce MODEYSO dose if unavoidable.
Mechanism
Dordaviprone is a CYP3A4 substrate; inhibitors increase its exposure
Source: NLP:dordaviprone